Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Authors: Borghaei H; Fox Chase Cancer Center, Philadelphia, PA., Gettinger S; Yale Comprehensive Cancer Center, New Haven, CT., Vokes EE; Univeristy of Chicago Medicine and Biologic Sciences Division, Chicago, IL., Chow LQM; University of Washington, Seattle Cancer Care Alliance, Seattle, WA., Burgio MA; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., de Castro Carpeno J; Hospital De Madrid, Norte Sanchinarro, Madrid, Spain., Pluzanski A; Maria Sklodowska-Curie Inst of Oncology, Warsaw, Poland., Arrieta O; Instituto Nacional De Cancerología, Mexico City, Mexico., Frontera OA; Centro de Investigación Clínica Bradford Hill and Centro Internacional de Estudios Clinicos, Santiago, Chile., Chiari R; Ospedale S. Maria Della Misericordia, Perugia, Italy., Butts C; Cross Cancer Institute, Edmonton, AB, Canada., Wójcik-Tomaszewska J; Provincial Center of Oncology in Gdańsk, Gdańsk, Poland., Coudert B; Centre Georges-François Leclerc, Dijon, France., Garassino MC; Instituto Nazionale per Lo Studio e La Cura, Milano, Italy., Ready N; Duke University Medical Center, Durham, NC., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., García MA; Hospital Universitario Virgen Del Rocio, Sevilla, Spain., Waterhouse D; Oncology Hematology Care, Inc, Cincinnati, OH., Domine M; Fundacion Jimenez Diaz, IIS-FJD Madrid, Spain., Barlesi F; Aix Marseille University, CNRS, INSERM, CRCM, APHM, Marseille, France., Antonia S; H. Lee Moffitt Cancer Center, Tampa, FL., Wohlleber M; Robert Bosch Cancer Center, Gerlingen, Germany., Gerber DE; UT Southwestern Medical Center, Dallas, TX., Czyzewicz G; John Paul II Hospital, Kraków, Poland., Spigel DR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, TN., Crino L; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Eberhardt WEE; Universitaetsmedizin Essen und Ruhrlandklinik, Essen, Germany., Li A; Bristol Myers Squibb, Princeton, NJ., Marimuthu S; Bristol Myers Squibb, Princeton, NJ., Brahmer J; Johns Hopkins Kimmel Cancer Center, Baltimore, MD.
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2021 Mar 01; Vol. 39 (7), pp. 723-733. Date of Electronic Publication: 2021 Jan 15.
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1527-7755
DOI:10.1200/JCO.20.01605